Evaluate Efficacy and Safety of Saxagliptin in Adult Patients With Type 2 Diabetes Inadequate Glycemic Control
Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
Saxagliptin is a new investigational medication being developed for treatment of type 2
diabetes. This study is designed to evaluate the efficacy and safety in adult patients with
inadequate glycaemic control with diet and exercise.